Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06393725 · ClinicalTrials.gov registry record · NA

Synchronous vs Asynchronous Remotely Delivered Lifestyle Interventions

A NA study of Obesity, sponsored by University of Connecticut.

Recruiting
Registry status
NA
Development phase
328
Enrollment target
1
Study location

NCT06393725: Recruiting NA study of Obesity, sponsored by University of Connecticut.

NCT06393725 is a NA study of Obesity that is actively recruiting participants, run by University of Connecticut. The registered enrollment target is 328 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06393725, a NA study of Obesity, is actively recruiting participants, sponsored by University of Connecticut.

RECRUITING
Registry status
NA
Development phase
328 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn if a group-based digital weight loss program that is delivered asynchronously (via an online platform) is as effective as one that is delivered synchronously (via weekly videoconference meetings). In the asynchronous condition, participants can engage with their group any time 24/7. In the synchronous condition, participants can engage with their group once a week at a videoconference meeting. The main questions it aims to answer are: Will participants in each condition lose about the same amount of weight? Will the participants in the asynchronous condition participate more than those in the synchronous condition? Will the participants in the asynchronous condition feel more connected to each other than those in the synchronous condition? Will the asynchronous condition cost less to deliver per pound lost than the synchronous condition? Participants will: Receive a digital weight loss program that lasts 1 year and then volunteer participants will be selected to lead the group for 1 year following the program, a phase called the "peer-led weight loss maintenance phase." Complete study assessments at baseline, 6, 12, 18, and 24 months.

Primary Outcome

Percent weight loss

Conditions Studied

Interventions

  • BEHAVIORAL Asynchronous Remote Lifestyle Intervention
  • BEHAVIORAL Synchronous Remote Lifestyle Intervention

Study Locations (1)

Connecticut

  • University of Connecticut - Storrs

Trial Details

FieldValue
Enrollment Target 328 participants
Start Date 2025-02-06
Est. Completion 2028-06-30
Phase NA
University of Connecticut

107 total trials

What NCT06393725 shows while recruiting

NCT06393725 is an interventional study that assigns participants to a tested intervention. The registered 328 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (60% lower).

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Asynchronous Remote Lifestyle Intervention is the first listed.

NCT06393725 reports a single indexed study location in Connecticut.

Frequently Asked Questions

What is clinical trial NCT06393725 about?

NCT06393725 is a clinical study titled "Synchronous vs Asynchronous Remotely Delivered Lifestyle Interventions". The goal of this clinical trial is to learn if a group-based digital weight loss program that is delivered asynchronously (via an online platform) is as effective as one that is delivered synchronously (via weekly videoconference meetings). In the asynchronous condition, participants can engage with...

What is the current status of trial NCT06393725?

This trial is currently recruiting. It is a NA study. The enrollment target is 328 participants. The study started on 2025-02-06. Estimated completion is 2028-06-30.

What conditions does trial NCT06393725 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT06393725?

The interventions under investigation include: Asynchronous Remote Lifestyle Intervention (BEHAVIORAL), Synchronous Remote Lifestyle Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06393725?

This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06393725 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06393725's enrollment target sits among peer trials

328 203rd of 1053 higher than 851 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05156983 · 328 participants · Phase 3

    A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery

  • NCT05380401 · 328 participants · NA

    Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants

  • NCT05548413 · 328 participants · NA

    Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies

  • NCT06036446 · 329 participants · NA

    LATe Cerclage in High-risk Pregnancies (LATCH)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06393725, the US trial registry maintained by the National Library of Medicine. NCT06393725 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.